189 related articles for article (PubMed ID: 27012644)
1. Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.
Daskivich TJ; Tan HJ; Litwin MS; Hu JC
J Urol; 2016 Sep; 196(3):672-7. PubMed ID: 27012644
[TBL] [Abstract][Full Text] [Related]
2. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
[TBL] [Abstract][Full Text] [Related]
3. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
4. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
5. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
6. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
Adejoro O; Alishahi A; Konety B
Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
[TBL] [Abstract][Full Text] [Related]
7. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities and causes of death in the management of localized T1a kidney cancer.
Patel HD; Kates M; Pierorazio PM; Gorin MA; Jayram G; Ball MW; Hyams ES; Allaf ME
Int J Urol; 2014 Nov; 21(11):1086-92. PubMed ID: 24931430
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
10. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.
Larcher A; Meskawi M; Valdivieso R; Boehm K; Trudeau V; Tian Z; Fossati N; Dell'Oglio P; Lughezzani G; Buffi N; Sun M; Karakiewicz P
World J Urol; 2016 Mar; 34(3):383-9. PubMed ID: 26047653
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
[TBL] [Abstract][Full Text] [Related]
12. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
13. Health status and use of partial nephrectomy in older adults with early-stage kidney cancer.
Tan HJ; Daskivich TJ; Shirk JD; Filson CP; Litwin MS; Hu JC
Urol Oncol; 2017 Apr; 35(4):153.e7-153.e14. PubMed ID: 27955941
[TBL] [Abstract][Full Text] [Related]
14. Implications on clinical management of the small renal mass in patients 80 years of age and older based on a retrospective review of the SEER database.
Russell DH; Wachtel MS; de Riese HW; Haynes AL; de Riese WT
Int Urol Nephrol; 2015 Sep; 47(9):1503-8. PubMed ID: 26216673
[TBL] [Abstract][Full Text] [Related]
15. Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.
Uhlig J; Kokabi N; Xing M; Kim HS
Radiology; 2018 Sep; 288(3):889-897. PubMed ID: 29969077
[TBL] [Abstract][Full Text] [Related]
16. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.
Huang WC; Atoria CL; Bjurlin M; Pinheiro LC; Russo P; Lowrance WT; Elkin EB
JAMA Surg; 2015 Jul; 150(7):664-72. PubMed ID: 26017316
[TBL] [Abstract][Full Text] [Related]
17. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.
Daskivich TJ; Lai J; Dick AW; Setodji CM; Hanley JM; Litwin MS; Saigal C;
Cancer; 2014 Dec; 120(23):3642-50. PubMed ID: 25042117
[TBL] [Abstract][Full Text] [Related]
18. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
19. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?
Smaldone MC; Egleston B; Uzzo RG; Kutikov A
J Urol; 2012 Dec; 188(6):2089-94. PubMed ID: 23083877
[TBL] [Abstract][Full Text] [Related]
20. National treatment trends among older patients with T1-localized renal cell carcinoma.
Kim SP; Gross CP; Meropol N; Kutikov A; Smaldone MC; Shah ND; Yu JB; Psutka S; Kiechle J; Abouassaly R
Urol Oncol; 2017 Mar; 35(3):113.e15-113.e21. PubMed ID: 27839926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]